KLOW 80 Peptide Blend
Four repair peptides, one 80mg vial.
$119.99 30% off
KLOW 80 is a four-peptide blend in a single 80mg vial: 50mg GHK-Cu, 10mg BPC-157, 10mg TB-500 and 10mg KPV. It is the GLOW combination with an inflammation arm added, covering collagen synthesis, blood supply, cell migration and inflammatory signalling in one reconstitution.
What is KLOW peptide blend?
KLOW peptide blend, sold here as KLOW 80, is a four-peptide research blend supplied as a single 80mg vial: 50mg GHK-Cu, 10mg BPC-157, 10mg TB-500 and 10mg KPV.
The name is the composition. KPV added to the GLOW three, eighty milligrams in total. The addition is not incidental: KPV is the only component in the blend whose primary research interest is suppressing inflammation rather than driving repair.
What is in the KLOW peptide blend
| Compound | Amount | Mechanism studied |
|---|---|---|
| GHK-Cu | 50 mg | Collagen and elastin synthesis, extracellular matrix remodelling |
| BPC-157 | 10 mg | Angiogenesis and connective tissue repair signalling |
| TB-500 | 10 mg | Actin polymerisation and cell migration |
| KPV | 10 mg | Anti-inflammatory signalling, NF-kB pathway modulation |
What KPV adds
KPV is a tripeptide, lysine-proline-valine, and it is the terminal fragment of alpha-melanocyte-stimulating hormone. The parent hormone has broad activity; the fragment retains the anti-inflammatory portion of it without the pigmentation signalling, which is why researchers study the three residues rather than the whole molecule.
That changes what the blend is for. GLOW 70 is a repair formulation. KLOW 80 is a repair formulation with an inflammation arm, and inflammation is frequently the thing limiting repair in the models these compounds get studied in. Whether adding it to the other three produces a better outcome than the three alone has not been tested.
Why these four are blended together
Structure, blood supply, cell migration, and inflammatory tone. Each compound covers one and largely leaves the others alone, which is the argument for combining them rather than increasing the dose of any single one.
As with any blend, the honest caveat applies: published studies of these four compounds administered together do not exist. The formulation is mechanistically coherent, not clinically demonstrated. Anyone selling it as proven synergy is ahead of the literature.
KLOW peptide research applications
Research interest spans wound and connective tissue repair models, skin structure and collagen work, gut lining and mucosal inflammation studies, and healthy-ageing research where matrix quality is the endpoint. GHK-Cu and BPC-157 carry the deepest published records of the four; KPV has a smaller but focused literature centred on inflammatory signalling.
Supplied as a laboratory research material only.
KLOW peptide for sale: specifications
| Specification | Detail |
|---|---|
| Contents | GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg, KPV 10mg |
| Total | 80 mg per vial |
| Form | Lyophilized powder, single sealed vial |
| Appearance | Blue to blue-green powder, from the copper complex |
| Purity | Minimum 98% per component, verified by HPLC |
| Identity | Confirmed by mass spectrometry |
| Testing | Independent third-party laboratory, per batch |
| Origin | Shipped from the United States |
KLOW 80 versus buying the four vials separately
Four separate vials means four diluent volumes and four concentrations to track. The blend fixes the ratio at manufacture, which removes that bookkeeping and lowers the combined cost, at the price of not being able to vary one component without varying all of them.
If a protocol needs KPV adjusted independently, buy KPV on its own. If the ratio above is the ratio you want, the blend is one reconstitution instead of four.
Reconstitution and handling
Supplied lyophilized. Reconstitute with bacteriostatic water, adding diluent slowly against the vial wall and letting the powder dissolve without agitation. Never shake. Because this is a fixed-ratio blend, the volume chosen sets the concentration of all four components simultaneously.
Storage and stability
Store the sealed lyophilized vial at minus 20 degrees Celsius, protected from light. The copper complex is light-sensitive, so light protection matters more here than for most single peptides. Reconstituted solution requires refrigeration at 2 to 8 degrees Celsius and a shorter usable window. Do not freeze the reconstituted solution.
Certificate of analysis for every batch
Each of the four components is tested individually rather than the mixture being assayed as one substance, because a blend is only as verifiable as its weakest part. Every batch is tested by an independent US laboratory for HPLC purity to a minimum of 98% per component and mass spectrometry identity, with the batch certificate published before purchase.
Why researchers buy KLOW 80 from Healio
Independent verification published in advance, minimum 98% purity per component, mass spectrometry identity confirmation, and US dispatch. The category sits under peptides for healing, and researchers who do not need the inflammatory arm can take GLOW 70, the same blend without KPV.
KLOW 80 FAQ
What is in the KLOW 80 blend?
50mg GHK-Cu, 10mg BPC-157, 10mg TB-500 and 10mg KPV in a single 80mg vial, supplied as a lyophilized powder.
What is the difference between KLOW 80 and GLOW 70?
KLOW 80 is GLOW 70 with 10mg of KPV added. KPV is an anti-inflammatory tripeptide derived from alpha-MSH, so KLOW carries an inflammation signalling component that GLOW does not.
What does the K in KLOW stand for?
KPV. The naming convention across the research supply market is simply KPV prefixed to GLOW, which is how the four-peptide version is distinguished from the three.
Is the KLOW 80 combination supported by research?
The four compounds individually have published literature, GHK-Cu and BPC-157 substantially so. The combination as a single formulation has not been studied directly. The blend rests on complementary mechanisms rather than trial data.
How is Healio KLOW 80 verified?
Independent third-party HPLC purity to a minimum of 98% per component and mass spectrometry identity confirmation, published per batch before purchase.
KLOW peptide vs GLOW peptide: the one component that differs
KLOW peptide is the four-compound blend: GHK-Cu, BPC-157, TB-500 and KPV. GLOW peptide is the same vial without the KPV. Ten milligrams of one tripeptide is the entire distinction, and it is what takes the total from 70mg to 80mg.
KPV is a fragment of alpha-MSH studied for its effect on inflammatory signalling rather than on collagen or blood supply. That gives the KLOW peptide blend a fourth mechanism the GLOW blend does not have, which matters if inflammation is part of what a study is measuring and is simply surplus if it is not.
Worth stating plainly: no published study has administered these four compounds together. Each has its own literature. The blend is a mechanistic argument, not a tested protocol. The full comparison is in GLOW vs KLOW: what the extra peptide actually changes.
Buy KLOW peptide with the COA published first
Every KLOW peptide vial ships against a batch certificate of analysis published before purchase rather than supplied on request. All four components are tested separately by HPLC to 98% or better, identity confirmed by mass spectrometry, and the batch number on the certificate is the batch in the box.
If certificates are new territory, how to read a certificate of analysis covers what each figure actually demonstrates, and every batch we have shipped is documented before purchase.
KLOW peptide for sale as a research material only. Related reading: KLOW 80 broken down component by component, KPV peptide benefits, BPC-157 and TB-500 together, and the peptides for healing collection.
Research focus
- Wound and connective tissue repair models
- Skin, collagen and elastin research
- Inflammatory signalling studies
- One vial instead of four reconstitutions
Who it’s for
For researchers focused on
| Scientific name | GHK-Cu + BPC-157 + TB-500 + KPV |
|---|---|
| CAS number | Blend, see components |
| Molecular formula | Multi-component |
| Molecular weight | Multi-component |
| Sequence | GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg + KPV 10mg |
| Purity | 98%+ per component (HPLC) |
| Form | Lyophilized powder |
| Appearance | Blue to blue-green powder |
Store the lyophilized powder at -20u00b0C, protected from light. Brief exposure to room temperature during shipping does not affect stability.
After reconstitution, keep refrigerated at 2 to 8u00b0C and use within the research window. Do not freeze the reconstituted solution.
For laboratory research use only. Reconstitute with bacteriostatic water and handle with appropriate protective equipment.





